Touch Medical Media coverage of data presented at EADV 2021:
touchIMMUNOLOGY were delighted to discuss with Prof. Rosalie Luiten (University of Amsterdam, Amsterdam, The Netherlands) the role of resident memory T cells in autoimmune vitiligo and tumour immunity, and how they could be used as a therapeutic target.
Her presentation entitled ‘Skin-resident T-cells as a potential new therapeutic target in vitiligo’ was given at the EADV 30th Congress, 29 Sep – 2 Oct.
Questions
- Could you tell us a little about tissue‐resident memory T cells? (0:16)
- How are tissue‐resident memory T cells implicated in the pathogenesis of autoimmune vitiligo? (1:38)
- What is the role of tissue‐resident memory T cells in mediating tumour immunity, for example in melanoma? (4:10)
- What are the next steps in understanding the significance of tissue‐resident memory T cells in autoimmune diseases and cancers, and what potential clinical applications might exist in the future? (7:01)
Disclosures: Prof. Rosalie Luiten has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Gina Furnival.
Filmed in coverage of the EADV’s 30th Congress, 29 Sep – 2 Oct 2021.
This content was developed by Touch Medical Media and is not affiliated with the European Academy of Dermatology & Venereology (EADV) or the congress.
